CAHP Score (Cardiac Arrest Hospital Prognosis)
Predicts 30-day mortality after out-of-hospital cardiac arrest (OHCA) to guide ICU admission and goals-of-care decisions.
Score interpretation
→ CAHP Low Risk: Predicted 30-day mortality <10%. Favourable prognosis. Admit to cardiac ICU; coronary angiography if indicated; targeted temperature management per protocol.
→ CAHP Intermediate Risk: Predicted 30-day mortality 10–50%. Discuss prognosis with family early. Full resuscitative care; reassess neurological trajectory.
→ CAHP High Risk: Predicted 30-day mortality >50%. Early goals-of-care discussion with family. Consider futility of further aggressive care. Palliative care involvement if appropriate.
Interpretation bands for the CAHP Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Amiodarone (IV — ICU/Peri-Arrest) · Antiarrhythmic (Class III)
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Mavacamten · Cardiac myosin inhibitor
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.